Patrizia Gena
Bari, 70125, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Correction: RG100204, a novel Aquaporin-9 inhibitor, reduces septic cardiomyopathy and multiple organ failure in murine sepsis.
Journal: Frontiers in immunology
Published: July 24, 2025
Selective Blockade of Two Aquaporin Channels, AQP3 and AQP9, Impairs Human Leukocyte Migration.
Journal: Cells
Published: April 18, 2025
Aquaporins in Biliary Function: Pathophysiological Implications and Therapeutic Targeting.
Journal: International journal of molecular sciences
Published: September 29, 2024
Spotlight on Secondary Metabolites Produced by an Early-Flowering Apulian Artichoke Ecotype Sanitized from Virus Infection by Meristem-Tip-Culture and Thermotherapy.
Journal: Antioxidants (Basel, Switzerland)
Published: June 25, 2024
Hepatocyte Aquaporins AQP8 and AQP9 Are Engaged in the Hepatic Lipid and Glucose Metabolism Modulating the Inflammatory and Redox State in Milk-Supplemented Rats.
Journal: Nutrients
Published: July 04, 2023
Characterization of the Aquaporin-9 Inhibitor RG100204 In Vitro and in db/db Mice.
Journal: Cells
Published: September 02, 2022
In Vitro and In Vivo Nutraceutical Characterization of Two Chickpea Accessions: Differential Effects on Hepatic Lipid Over-Accumulation.
Journal: Antioxidants (Basel, Switzerland)
Published: February 28, 2020
Stopped-flow Light Scattering Analysis of Red Blood Cell Glycerol Permeability.
Journal: Bio-protocol
Published: December 23, 2019
Aquaporin-9 is involved in the lipid-lowering activity of the nutraceutical silybin on hepatocytes through modulation of autophagy and lipid droplets composition.
Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids
Published: October 14, 2019
Last Updated: 09/26/2026